Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

186.29
Delayed Data
As of 3:59pm ET
 +1.07 / +0.58%
Today’s Change
150.06
Today|||52-Week Range
203.30
+0.68%
Year-to-Date

Today’s Trading

Previous close185.22
Today’s open183.40
Day’s range182.91 - 187.53
Volume1,171,209
Average volume (3 months)2,160,195
Market cap$41.8B
Dividend yield--
Data as of 3:59pm ET, 07/06/2015

Growth & Valuation

Earnings growth (last year)+156.69%
Earnings growth (this year)-2.53%
Earnings growth (next 5 years)+19.69%
Revenue growth (last year)+46.49%
P/E ratio63.7
Price/Sales16.84
Price/Book11.17

Competitors

 Today’s
change
Today’s
% change
SHPGShire-1.21-0.49%
MYLMylan NV+0.61+0.87%
VRTXVertex Pharmaceutica...-2.45-1.87%
PRGOPerrigo Company PLC+1.74+0.95%
Data as of 3:59pm ET, 07/06/2015

Financials

Next reporting dateJuly 23, 2015
EPS forecast (this quarter)$1.39
Annual revenue (last year)$2.2B
Annual profit (last year)$656.9M
Net profit margin29.66%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
David L. Hallal
Chief Financial Officer &
Executive Vice President
Vikas Sinha
Corporate headquarters
Cheshire, Connecticut

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers